You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
以嶺藥業(002603.SZ)7個藥品進入國家醫保目錄(2019版)
格隆匯 08-21 16:10

格隆匯8月21日丨以嶺藥業(002603.SZ)公佈,根據國家醫療保障局、人力資源社會保障部於2019年8月20日下發的《關於印發 <國家基本醫療保險、工傷保險和生育保險藥品目錄> 的通知》【醫保發[2019]46號】,公司共有7個藥品入選了《國家基本醫療保險、工傷保險和生育保險藥品目錄(2019版)》(“國家醫保目錄”),均為公司獨家藥品。其中4個藥品進入甲類,3個藥品進入乙類,調整醫保分類藥品1個。

此次公司產品納入新版國家醫保目錄將使更多患者受益,有利於這些產品的市場銷售,對公司經營業績的影響暫無法估計,短期內不會對公司的業績產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account